Southern California-based cardiac ablation technology developer Adagio Medical, Inc. closed a $42.5m series E equity financing on 12 November.
The new funds will support the ongoing investigational device exemption (IDE) trial of Adagio’s intelligent continuous lesion ablation cryoablation...







